These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 37894344)

  • 61. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
    Wang Y; Wang D; Yang L; Zhang Y
    Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression.
    Chen H; Tang C; Tan C; Wu F; Li Z; Ji W; Lu L; Xu C; Shen Z; Huang Y
    J Oncol; 2022; 2022():3445350. PubMed ID: 36284632
    [No Abstract]   [Full Text] [Related]  

  • 63. Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages.
    Zhou TY; Zhou YL; Qian MJ; Fang YZ; Ye S; Xin WX; Yang XC; Wu HH
    J Pharmacol Sci; 2018 Oct; 138(2):89-95. PubMed ID: 30340922
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma.
    Liu Q; Huang W; Liang W; Ye Q
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities.
    Han J; Dong L; Wu M; Ma F
    Front Immunol; 2023; 14():1160340. PubMed ID: 37251409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.
    Zhou Z; Hu Y; Wu Y; Qi Q; Wang J; Chen L; Wang F
    Mol Immunol; 2022 Nov; 151():218-230. PubMed ID: 36179604
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autophagy Drives Galectin-1 Secretion From Tumor-Associated Macrophages Facilitating Hepatocellular Carcinoma Progression.
    Davuluri GVN; Chen CC; Chiu YC; Tsai HW; Chiu HC; Chen YL; Tsai PJ; Kuo WT; Tsao N; Lin YS; Chang CP
    Front Cell Dev Biol; 2021; 9():741820. PubMed ID: 34552935
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes.
    Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
    World J Surg Oncol; 2019 Jun; 17(1):97. PubMed ID: 31170995
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression.
    Bao D; Zhao J; Zhou X; Yang Q; Chen Y; Zhu J; Yuan P; Yang J; Qin T; Wan S; Xing J
    Oncogene; 2019 Jun; 38(25):5007-5020. PubMed ID: 30894684
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting tumor-associated macrophages for cancer immunotherapy.
    Shu Y; Cheng P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma.
    Guerra P; Martini A; Pontisso P; Angeli P
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509293
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting tumor-associated macrophages for cancer treatment.
    Li M; He L; Zhu J; Zhang P; Liang S
    Cell Biosci; 2022 Jun; 12(1):85. PubMed ID: 35672862
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy.
    Xiao L; Wang Q; Peng H
    Front Immunol; 2023; 14():1157291. PubMed ID: 37426676
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation.
    Papadakos SP; Machairas N; Stergiou IE; Arvanitakis K; Germanidis G; Frampton AE; Theocharis S
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626849
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression.
    Wang L; Hu YY; Zhao JL; Huang F; Liang SQ; Dong L; Chen Y; Yu HC; Bai J; Yang JM; Fan JY; Feng L; Li SZ; Han H; Qin HY
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948650
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Polyamine Signal through HCC Microenvironment: A Key Regulator of Mitochondrial Preservation and Turnover in TAMs.
    Liu Q; Yan X; Li R; Yuan Y; Wang J; Zhao Y; Fu J; Su J
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256070
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long non-coding RNA GAS5 overexpression inhibits M2-like polarization of tumour-associated macrophages in SMCC-7721 cells by promoting PTEN expression.
    Wang X; Li FY; Zhao W; Gao ZK; Shen B; Xu H; Cui YF
    Int J Exp Pathol; 2020 Dec; 101(6):215-222. PubMed ID: 33146930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
    Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection.
    Shu QH; Ge YS; Ma HX; Gao XQ; Pan JJ; Liu D; Xu GL; Ma JL; Jia WD
    J Cell Mol Med; 2016 Jun; 20(6):1024-35. PubMed ID: 26843477
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
    Ge Z; Ding S
    Front Oncol; 2020; 10():590941. PubMed ID: 33224886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.